2.630EUR-2.95%Mkt Cap: 40.29M EURP/E: 14.72Last update: 2026-05-29
Biohit Oyj, a biotechnology company, manufactures and sells bind acetaldehyde, diagnostic products, and systems for diagnostic analysis for the use of research institutions, healthcare, and industry worldwide. The compan…
Industry Peers
Medical Devices152.01BUSDP/E 24.4
115.59BUSDP/E 34.9
71.08BUSDP/E 20.0
54.41BSEKP/E 101.6
52.05BDKKP/E 22.0
51.03BUSDP/E 47.9
50.55BSEKP/E 21.4
38.34BEURP/E 18.1
Indicators:|
Key Statistics
Company
Market Cap40.29M EUR
Enterprise Value36.71M EUR
Revenue (TTM)15.73M EUR
Gross Profit10.75M EUR
Net Income (TTM)2.74M EUR
Revenue/Share1.036 EUR
Last Price2.630 EUR
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees46
CountryFI
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)14.72
P/E (Forward)15.47
PEG7.04
EV/EBITDA11.72
EV/Revenue2.33
P/S2.54
P/B2.68
EPS (TTM)0.18
EPS (Forward)0.17
52W Range
2.20027% of range3.780
52W High3.780 EUR
52W Low2.200 EUR
Profitability
Gross Margin68.33%
Oper. Margin22.23%
EBITDA Margin19.92%
Profit Margin17.40%
ROE18.33%
ROA13.82%
Growth
Revenue Growth21.10%
Earnings Growth32.60%
Cash Flow & Leverage
Operating CF-748.00K EUR
CapEx (TTM)615.00K EUR
FCF Margin13.51%
FCF Yield5.27%
Net Debt-3.26M EUR
Net Debt/EBITDA-1.04
Balance Sheet
Debt/Equity0.11
Current Ratio2.56
Quick Ratio2.34
Book Value/Sh0.9830 EUR
Cash/Share0.3190 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 EUR
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div DateApr 15, 2014
Pay Date—
Analyst Consensus
Rating—
Target (Mean)3.500 EUR
Target Range3.500 EUR – 3.500 EUR
# Analysts1
Ownership
Shares Out.12.23M
Float4.50M
Insiders49.85%
Institutions0.00%
Technical
SMA 502.413 (+9.0%)
SMA 2002.917 (-9.9%)
Beta0.56
S&P 52W Chg27.94%
Avg Vol (30d)9.91K
Avg Vol (10d)9.69K
Technical Indicators
RSI (14)66.7
MACD0.0002
MACD Signal-0.0233
MACD Hist.+0.0235
BB Upper2.679 EUR
BB Middle2.438 EUR
BB Lower2.198 EUR
BB Width19.71%
ATR (14)0.1574 EUR
Vol Ratio (20d)0.77x